Schechter G P, Soehnlen F
Blood. 1978 Aug;52(2):261-71.
Mononuclear leukocytes isloated from the blood of previously treated patients with advanced active Hodgkin disease contained high concentrations of monocytes and showed poor lymphocyte blastogenesis to mitogens. In five of eight patients with disseminated disease, blastogenesis became normal or improved markedly when the leukocyte suspensions were depleted of monocytes before culture. Addition of autologous macrophages to the monocyte-depleted lymphocytes resulted in a reappearance of the inhibition of blastogenesis. Monocyte inhibition was associated with the presence of active disease, lymphocytopenia, and low lymphocyte/monocyte ratios in the peripheral blood. The role of previous treatment is uncertain, since inhibition tended to disappear when the patients were retreated. Inhibitory monocyte-lymphocyte interactions may be one of the causes of impaired cell-mediated immunity in Hodgkin disease.
从先前接受过治疗的晚期活动性霍奇金病患者血液中分离出的单核白细胞含有高浓度的单核细胞,并且对有丝分裂原的淋巴细胞增殖反应较差。在8例播散性疾病患者中的5例,当白细胞悬液在培养前去除单核细胞后,增殖反应变得正常或明显改善。将自体巨噬细胞添加到去除单核细胞的淋巴细胞中导致增殖抑制再次出现。单核细胞抑制与活动性疾病的存在、淋巴细胞减少以及外周血中低淋巴细胞/单核细胞比值有关。先前治疗的作用尚不确定,因为当患者再次接受治疗时抑制作用往往会消失。抑制性单核细胞-淋巴细胞相互作用可能是霍奇金病中细胞介导免疫受损的原因之一。